Evidence map›Paper›PMID 33692223›Full record

ArticleThe Journal of veterinary medical science2021

Usefulness of cardiac hormones for evaluating valvular disease in cynomolgus monkeys (Macaca fascicularis).

Chungyu Pai, Shunya Nakayama, Yasuyo Ito-Fujishiro, Kiichi Kanayama, Yoshiko Munesue, Tadashi Sankai, Yasuhiro Yasutomi, Hiroshi Koie, Naohide Ageyama

Open access · diamondAbstract read
In one paragraph

Article in The Journal of veterinary medical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chungyu PaiLaboratory of Veterinary Physiology/Pathophysiology, College of Bioresource Science, Nihon University, Kanagawa 252-0880, Japan.
Shunya NakayamaLaboratory of Veterinary Physiology/Pathophysiology, College of Bioresource Science, Nihon University, Kanagawa 252-0880, Japan.
Yasuyo Ito-FujishiroLaboratory of Veterinary Physiology/Pathophysiology, College of Bioresource Science, Nihon University, Kanagawa 252-0880, Japan.
Kiichi KanayamaLaboratory of Veterinary Physiology/Pathophysiology, College of Bioresource Science, Nihon University, Kanagawa 252-0880, Japan.
Yoshiko MunesueThe Corporation for Production and Research of Laboratory Primates, Ibaraki 305-0843, Japan.
Tadashi SankaiTsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki 305-0843, Japan.
Yasuhiro YasutomiTsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki 305-0843, Japan.
Hiroshi KoieLaboratory of Veterinary Physiology/Pathophysiology, College of Bioresource Science, Nihon University, Kanagawa 252-0880, Japan.
Naohide AgeyamaTsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki 305-0843, Japan.
Nihon University · JPNational Institute of Biomedical Innovation, Health and Nutrition · JPCorporation for Production and Research of Laboratory Primates · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonhuman primates are commonly used as experimental animals due to their biological resemblance to humans. In patients with cardiac disease, the levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) tend to increase in response to cardiac damage, and they are thus used as indicators for the diagnosis of human heart failure. However, no reference values for ANP and BNP have been reported for heart disease in nonhuman primates. In this study, we recorded the age, sex, and body weight of 202 cynomolgus monkeys, and performed evaluations to assess the ANP and BNP levels, electrocardiography and echocardiography, and accordingly divided the monkeys into two groups: healthy monkeys and those with spontaneous cardiac disease. Statistical analysis was performed to determine the relationship of ANP and BNP with the factors of age, sex, and body weight. No significant relationship was found between the levels of ANP and BNP and the factors of age, sex, and body weight. However, both the ANP and BNP levels were significantly different between the healthy monkeys and monkeys with valvular disease. Similar to humans, the ANP and BNP levels tended to increase with the progression of cardiac disease in monkeys. Based on these results, we concluded that ANP and BNP are indicators of cardiac disease in nonhuman primates, and that this nonhuman primate cardiac disease model is applicable for cardiology research in humans.

Indexed as

Heart FailureHeart Valve DiseasesAnimalsAtrial Natriuretic FactorHeartHumansMacaca fascicularisNatriuretic Peptide, BrainAtrial Natriuretic FactorNatriuretic Peptide, Brainatrial natriuretic peptide (ANP)brain natriuretic peptide (BNP)cynomolgus monkeysnonhuman primatevalvular disease

Identifiers

PMID33692223
PMCPMC8111363
OpenAlexW3134996988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.